Completed PHASE4 INTERVENTIONAL NCT00437333

Metformin Suspension and Insulin Sensitivity

Insulin Sensitivity After Metformin Suspension in Normal-Weight Women With Polycystic Ovary Syndrome

Sponsor: University Magna Graecia

Updated 4 times since 2017 Last updated: Feb 20, 2007 Started: Dec 31, 2003 Completion: Apr 30, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00437333, this PHASE4 trial focuses on Polycystic Ovary Syndrome and remains completed. Sponsored by University Magna Graecia, it has been updated 4 times since 2003, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jan 2017 — Jan 2021 [monthly]

Completed PHASE4

First recorded

Dec 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Magna Graecia

Data source: University Magna Graecia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Catanzaro, Italy